Context Therapeutics Inc (CNTX) insider trading

Every open-market stock purchase and sale by Context Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

No open-market insider trades in the last 12 months.
Last insider buy: Martin A. Lehr (CEO), $70.1K, 16 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.24 on Oct 22, 2026.

Recent CNTX insider trades

Date	Insider	Trade	Value
Jun 24, 2026	Luke Nathaniel Walker (Director)	Bought (not open market)	—
Jun 24, 2026	Karen L. Smith (Director)	Bought (not open market)	—
Jun 24, 2026	Philip W. Kantoff (Director)	Bought (not open market)	—
Jun 24, 2026	Linda West (Director)	Bought (not open market)	—
Jun 24, 2026	Jennifer Evans Stacey (Director)	Bought (not open market)	—
Jun 24, 2026	Andy Pasternak (Director)	Bought (not open market)	—
Feb 19, 2026	Alex C. Levit (C-suite exec)	Bought (not open market)	—
Feb 19, 2026	Karen Deborah Chagin (C-suite exec)	Bought (not open market)	—
Feb 19, 2026	Martin A. Lehr (CEO)	Bought (not open market)	—
Feb 19, 2026	Jennifer Lynn Minai-Azary (CFO)	Bought (not open market)	—

Who's trading CNTX

Luke Nathaniel Walker, Director: other filings, last Jun 24, 2026
Andy Pasternak, Director: other filings, last Jun 24, 2026
Karen L. Smith, Director: other filings, last Jun 24, 2026
Jennifer Evans Stacey, Director: other filings, last Jun 24, 2026
Linda West, Director: other filings, last Jun 24, 2026
Philip W. Kantoff, Director: other filings, last Jun 24, 2026
Jennifer Lynn Minai-Azary, CFO: other filings, last Feb 19, 2026
Karen Deborah Chagin, C-suite exec: other filings, last Feb 19, 2026
Martin A. Lehr, CEO: other filings, last Feb 19, 2026
Alex C. Levit, C-suite exec: other filings, last Feb 19, 2026

Get free alerts when an insider at Context Therapeutics Inc files a new trade →